98%
921
2 minutes
20
Background: Infective endocarditis (IE) after transcatheter pulmonary valve replacement (TPVR) remains a significant concern. Although there are overall good short-term and long-term hemodynamic outcomes, limited data exist comparing postimplantation echocardiographic findings leading to IE.
Objectives: To compare the progressive echocardiographic performance of percutaneous implanted pulmonary valves before the development of IE.
Methods: This is a single-center retrospective cohort study of all patients who underwent successful TPVR using either Medtronic Melody or Edwards Sapien valves from 2009 to 2021. Patient demographics, procedural details, and yearly echocardiographic findings were collected and compared as appropriate. The risk of IE was compared between groups defined by baseline characteristics using time-to-event methods. Joint modeling was used to evaluate the association between peak-to-peak gradient trajectories over time and the risk of IE. The predictive performance of using peak-to-peak gradient thresholds to predict IE was evaluated using receiver operating characteristic (ROC) analyses.
Result: A total of 226 patients underwent successful TPVR of which 26 patients developed IE. The annualized incidence of IE was 2.96 per 100 patient years. Patients with and without IE had similar ages, weights, and diagnoses. All IE cases were with the Melody valves. Patients who had higher postimplantation echo-derived peak instantaneous gradients (PGs) were significantly more likely to develop IE. Patients with immediate postimplant invasive peak to peak gradient ≥ 15 mmHg were more likely to develop IE. Higher PGs over time were significantly associated with a higher risk of IE (HR 1.04 per mmHg; 95% CI: 1.00-1.07, p = 0.03). ROC analyses indicate that PGs over time have poor predictive performance of IE.
Conclusion: Echocardiographic performance following TPVR was generally acceptable and similar to other studies. Patients who ultimately developed IE trended to have higher PPG post-TPVR and higher gradients over time before the development of IE. The rate of change of echo-derived gradients in patients with lower initial invasive gradients was more pronounced. These findings suggest that longitudinal monitoring of echocardiographic gradient could provide targeted surveillance in those identified at higher risk for IE.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12412345 | PMC |
http://dx.doi.org/10.1002/ccd.70027 | DOI Listing |
Egypt Heart J
September 2025
Department of Cardiology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Background: Long-term outcomes of transcatheter mitral valve edge-to-edge repair (TEER) are compared with medical therapy remain under investigation. This study evaluated the 3-year effects of MitraClip on mitral regurgitation (MR) severity, ventricular remodeling, and clinical outcomes in high surgical-risk patients.
Methods: A single-center retrospective cohort included 31 MitraClip patients (2016-2023) and 30 contemporaneous controls on maximally tolerated guideline-directed medical therapy.
Clin Res Cardiol
September 2025
AGEL Hospital Trinec-Podlesi, Konska 453, Trinec, 739 61, Czech Republic.
Background: Pulmonary hypertension (PH) often coexists in patients undergoing transcatheter edge-to-edge mitral valve repair procedure (M-TEER). Its pre-procedural severity is considered a negative prognostic marker. Whether the post-procedural PH resulting from M-TEER can also serve as a long-term prognostic marker is unknown.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Department of Cardiology, Monaldi Hospital, Naples, Italy. Electronic address:
Background: Pulmonary hypertension is a contraindication to correction of tricuspid regurgitation.
Case Summary: A 75-year-old Italian woman with previous episodes of right heart failure was diagnosed with World Health Organization (WHO) functional class IV pulmonary arterial hypertension (PAH) complicated by torrential tricuspid regurgitation. After 6 months of treatment with diuretic agents, macitentan, and tadalafil, she improved to WHO functional class III, with a pulmonary vascular resistance (PVR) decreasing from 5.
Rev Esp Cardiol (Engl Ed)
September 2025
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, España; Servicio de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, España.
Introduction And Objectives: This report presents the 2024 activity data from the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC).
Methods: All interventional cardiology laboratories in Spain were invited to complete an online survey. Data analysis was conducted by an external company and then reviewed and presented by the ACI-SEC board.
Am J Med Sci
September 2025
The George Washington University School of Medicine and Health Sciences, Washington, DC.
Background: In transcatheter aortic valve replacement (TAVR), there is a notable "diabetes discrepancy", where worse/better/similar outcomes were all found for patients with diabetes mellitus (DM). Such divergent findings pose a challenge for clinicians to accurately assess the risks for DM patients undergoing TAVR. We hypothesized the presence of chronic complications could be linked to worse post-TAVR outcomes in DM patients.
View Article and Find Full Text PDF